Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5′-(3′-phenylisoxazolino)methyl]-8-hydroxyquinoline: Preliminary study

Farmaco

Volumn 59, Issue 3, 2004, Pages 195-199

  Dardari, Zainaba ^a   Lemrani, Meryem ^b   Bahloul, Abdelmejid ^a   Sebban, Abdelfatah ^a   Hassar, Mohammed ^b   Kitane, Said ^c   Berrada, Mohammed ^a   Boudouma, Mohammed ^a  

^a HASSAN II UNIVERSITY   (Morocco)

^b Institut Pasteur du Maroc   (Morocco)

^c Ecole Nationale de l'Industrie Minerale   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

7 [5' (3' PHENYLISOXAZOLINO)METHYL] 8 HYDROXYQUINOLINE; 8 QUINOLINOL DERIVATIVE; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; IC 50; IN VITRO STUDY; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TROPICA; NONHUMAN;

EID: 1342279423     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2003.11.001     Document Type: Article

References (28)

1. Dejeux P. The increase in risk factors for leishmaniasis worldwide. Trans. R. Soc. Trop. Med. Hyg. 95:2001;239-243.
2. Rioux J.A., Lanotte G., Petter F., Dereure J., Akalay O., Pratlong F., et al. Les leishmanioses cutanées du bassin Méditerranéen occidental: de l'identification enzymatique à l'analyse éco-épidémiologique. L'exemple de trois « foyers », Tunisien, Marocain et Français. Rioux. Leishmania. Taxonomie et phylogénèse. Application éco-épidémiologique Colloques internationaux CNRS. 1986;365-395 IMEE, Montpellier.
3. Marty P., Le Fichoux Y., Pratlong F., Rioux J.A., Rostin G., Lacour J.P. Cutaneous leishmaniasis due to Leishmania tropica in a young Moroccan child observed in Nice, France. Trans. R. Soc. Trop. Med. Hyg. 83:1989;510.
4. Guessous-Idrissi N., Chiheb S., Hamdani A., Riyad M., Bichichi M., Hamdani S., et al. Cutaneous leishmaniasis: an emerging epidemic focus of leishmania tropica in north Morocco. Trans. R. Soc. Trop. Med. Hyg. 91:1997;660-663.
5. Nejjar R., Lemrani M., Malki A., Ibrahimy S., Amarouch H., Benslimane A. Canine leishmaniasis due to Leishmania infantum MON-1 in northern Morocco. Parasite. 5:1998;325-330.
6. Lemrani M., Nejjar R., Pratlong F. A new leishmania tropica zymodeme causative agent of canine visceral leishmaniasis in northern Morocco. Ann. Trop. Med. Parasitol. 96:(6):2002;637-638.
7. F. Modabber, Chagas'disease, In: Tropical Disease Research, World Health Organisation, Geneva, 1993 Ninth Programme Report of the UNDP/World Bank/WHO.
8. Sereno D., Lemesre J.P. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob. Agent. Chemother. 41:(5):1997;972-976.
9. Shen A.Y., Chen C.P., Roffler S. A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline. Life Sci. 64:1999;813-825.
10. Collery P., Lechenault F., Cazabat A., Juvin E., Khassanova L., Evangelou A., et al. Inhibitory effects of gallium chloride and tris (8-quinolinolate) gallium III on A549 human malignant cell line. Anticancer Res. 20:2000;955-958.
11. Tzeng C.C., Lee K.H., Wang T.C., Han C.H., Chen Y.L. Synthesis and cytotoxic evaluation of a series of gamma-substituted gamma-aryloxymethyl-alpha- methylene-gamma-butyrolactones against cancer cells. Pharm. Res. 17:2000;715-719.
12. Lentz D.L., Gershon H., Marini H. New antifungal agents that inhibit the growth of Candida species: dichlorinated 8-quinolinols. Mycopathologia. 147:(3):1999;117-120.
13. Hoi B., Ki-Wei H., Royer R. Contribution à l'étude de la migration allylique chez les phénols. Bull. Soc. Chim. Fr. 12:1945;866-871.
14. Padwa A. 1,3-Dipolar Cycloaddition Chemistry. 1984;John Wiley Sons, New York.
15. Tarssel B.G. Nitrile Oxines, Nitrines and Nitronates in Organic Synthesis, Novel Strategies in Synthesis. 1987;V.C.H publishers, INC, New York.
16. Soufiaoui M., Jazouli H. Cycloaddition dipolar-1,3 des arylnitriloxydes sur les dihydro-1,2-quinoleine N-substituées. J. Heterocyclic. Chem. 26:1989;1527-1530.
17. Sebban A., Bahloul A., Berrada M., Kitane S., Bougrin K., Soufiaoui M. Cycloaddition dipolar-1,3: Etude de la régiosélectivité des nitrilimines disubstituées et des arylnitriloxydes avec l'isochromène. Journal de la Société Chimique de Tunisie. 4:(11):2002;1403-1409.
18. Bahloul A., Sebban A., Dardari Z., Boudouma M., Kitane S., Belghiti T., et al. New Heterocycles from 8-hydroxyquinoline via Dipolar 1,3-Cycloadditions: Synthesis and Biological evaluation. J. Heterocyclic. Chem. 40:2003;243-248.
19. Hatimi S., Boudouma M., Bichichi M., Chaib N., Guessous-Idrissi N. Evaluation in vitro de l'activité antileishmanienne d'Artemisia herba alba Asso. Bulletin de la société de Pathologie Exotique. 94:(1):2001;29-31.
20. Belazzoug S., Ammar-Khodja A., Belkaid M., Tabet-Derraz O. la leishmaniose cutanée du Nord de l'Algérie. Bulletin de la société de Pathologie Exotique. 78:1985;615-622.
21. Gramiccia M., Gradoni L. Successful in vitro isolation and cultivation of Italian dermotropic strains of Leishmania infantum sensu lato. Trans. R. Soc. Trop. Med. Hyg. 83:1989;76.
22. Rioux J.A., Lanotte G. Leishmania infantum as a cause of cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:1990;898.
23. Ben-Ismail R., Smith D.F., Ready P., Ayadi A., Gramiccia M., Ben-Osman A., et al. Sporadic cutaneous leishmaniasis in north Tunisia: Identification of the causative agent as Leishmania infantum by the use of a diagnostic deoxyribonucleic acid probe. Trans. R. Soc. Trop. Med. Hyg. 86:1992;508-810.
24. Lemrani M., Nejjar R., Benslimane A. A new focus of cutaneous leishmaniasis due to Leishmania infantum in northern Morocco. Giornale Italiano di Medicina Tropicale. 4:1999;81-82.
25. Faraut-Gambarelli F., Piarroux R., Deniau M., Giusiano B., Marty P., Michel G., et al. In vitro and in vivo resistance of Leishmania infantum to Meglumine Antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agent. Chemother. 41:(4):1997;827-830.
26. Berman J.D., Hanson W.L., Chapman W.L., Alving C.R., Lopez-Berestein G. Antileishmanial activity of liposome-encapsulated amphotericin B in Hamsters and Monkeys. Antimicrob. Agent. Chemoth. 30:1986;847-851.
27. Murray H.W. Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. Int. J. Infect. Dis. 4:2000;158-177.
28. 8-hydroxyquinoline, EMEA/MRL/464/98-Final. 1998.